Transcenta to Present Clinical Trial Data of TST001 and MSB0254 at 2022 ASCO Annual Meeting ...Middle East

SUZHOU, China, April 28, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that the...

Hence then, the article about transcenta to present clinical trial data of tst001 and msb0254 at 2022 asco annual meeting was published today ( Friday 29/04/2022 - 05:42 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Transcenta to Present Clinical Trial Data of TST001 and MSB0254 at 2022 ASCO Annual Meeting )

Also on site :

• Makeup Artist Alexis Stone’s Jim Carrey Transformation Claim Divides the Internet
• NASDAQ: CRWV: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against CoreWeave, Inc. (CRWV)
• Colorado Buffaloes quarterback Dominiq Ponder dies